These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 10589373)

  • 1. Clinical pharmacokinetics of clarithromycin.
    Rodvold KA
    Clin Pharmacokinet; 1999 Nov; 37(5):385-98. PubMed ID: 10589373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
    Shi J; Montay G; Bhargava VO
    Clin Pharmacokinet; 2005; 44(9):915-34. PubMed ID: 16122280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.
    Hsu A; Granneman GR; Bertz RJ
    Clin Pharmacokinet; 1998 Oct; 35(4):275-91. PubMed ID: 9812178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin clinical pharmacokinetics.
    Fraschini F; Scaglione F; Demartini G
    Clin Pharmacokinet; 1993 Sep; 25(3):189-204. PubMed ID: 8222460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of clarithromycin into middle ear fluid of children with acute otitis media.
    Gan VN; McCarty JM; Chu SY; Carr R
    Pediatr Infect Dis J; 1997 Jan; 16(1):39-43. PubMed ID: 9002099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between ritonavir and clarithromycin.
    Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
    Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
    Womble AY; Giguère S; Lee EA; Vickroy TW
    Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
    Brophy DF; Israel DS; Pastor A; Gillotin C; Chittick GE; Symonds WT; Lou Y; Sadler BM; Polk RE
    Antimicrob Agents Chemother; 2000 Apr; 44(4):978-84. PubMed ID: 10722500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.
    Shi J; Chapel S; Montay G; Hardy P; Barrett JS; Sica D; Swan SK; Noveck R; Leroy B; Bhargava VO
    Int J Clin Pharmacol Ther; 2005 Mar; 43(3):123-33. PubMed ID: 15792396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.
    He G; Massarella J; Ward P
    Clin Pharmacokinet; 1999 Dec; 37(6):471-84. PubMed ID: 10628898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
    Ito K; Ogihara K; Kanamitsu S; Itoh T
    Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections.
    Ciervo CA; Shi J
    Curr Med Res Opin; 2005 Oct; 21(10):1641-50. PubMed ID: 16238904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
    Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
    Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.